Identification of Various Recombinants in a Patient Coinfected With the Different SARS‐CoV‐2 Variants
Influenza and Other Respiratory Viruses · 2024
DOI: 10.1111/irv.13340 ↗Kurz gefasst
Fallbericht in der Zeitschrift Influenza and Other Respiratory Viruses, 2024. Verfasst von Yusuke Sayama und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Virology, Tohoku University of Graduate School of Medicine, Sendai, Miyagi, Japan. Hauptthemen laut MEDLINE: Coinfection, COVID-19, Genome, Viral, Recombination, Genetic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Miyagi Prefecture, Japan, AMED, JSPS KAKENHI.
Abstract (Originalsprache)
Background
Viral recombination that occurs by exchanging genetic materials between two viral genomes coinfecting the same host cells is associated with the emergence of new viruses with different virulence. Herein, we detected a patient coinfected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Delta and Omicron variants and identified various recombinants in the SARS‐CoV‐2 full‐length spike gene using long‐read and Sanger sequencing.
Methods
Samples from five patients in Japan with household transmission of coronavirus disease 2019 (COVID‐19) were analyzed using molecular assays for detection and identification of SARS‐CoV‐2. Whole‐genome sequencing was conducted using multiplex PCR with short‐read sequencing.
Results
Among the five SARS‐CoV‐2‐positive patients, the mutation‐specific assay identified the Delta variant in three, the Omicron variant in one, and an undetermined in one. The undermined patient was identified as Delta using whole‐genome sequencing, but samples showed a mixed population of Delta and Omicron variants. This patient was analyzed for viral quasispecies by long‐read and Sanger sequencing using a full‐length spike gene amplicon. In addition to the Delta and Omicron sequences, the viral quasispecies analysis identified nine different genetic recombinant sequences with various breakpoints between Delta and Omicron sequences. The nine detected recombinant sequences in the spike gene showed over 99% identity with viruses that were detected during the Delta and Omicron cocirculation period from the United States and Europe.
Conclusions
This study demonstrates that patients coinfected with different SARS‐CoV‐2 variants can generate various viral recombinants and that various recombinant viruses may be produced during the cocirculation of different variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Virology, Tohoku University of Graduate School of Medicine, Sendai, Miyagi, Japan.
- Department of Microbiology, Miyagi Prefectural Institute of Public Health and Environment, Sendai, Miyagi, Japan.
ORCID-Profile: Yusuke Sayama, Clyde Dapat, Hitoshi Oshitani
Förderung
- Miyagi Prefecture, Japan
- AMED
- JSPS KAKENHI
Zitieren
APA
Sayama, Y., Sakagami, A., Okamoto, M., Sakamoto, M., Koizumi, H., Kimura, Y., Dapat, C., Saito, M., Suzuki, Y., Sasaki, M., Sugawara, N., & Oshitani, H. (2024). Identification of Various Recombinants in a Patient Coinfected With the Different SARS‐CoV‐2 Variants. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.13340
Vancouver
Sayama Y, Sakagami A, Okamoto M, Sakamoto M, Koizumi H, Kimura Y, et al. Identification of Various Recombinants in a Patient Coinfected With the Different SARS‐CoV‐2 Variants. Influenza and Other Respiratory Viruses. 2024. doi:10.1111/irv.13340
BibTeX
@article{Sayama2024,
author = {Sayama, Yusuke and Sakagami, Akie and Okamoto, Michiko and Sakamoto, Masahiro and Koizumi, Hikari and Kimura, Yoko and Dapat, Clyde and Saito, Mayuko and Suzuki, Yuko and Sasaki, Mie and Sugawara, Naoko and Oshitani, Hitoshi},
title = {Identification of Various Recombinants in a Patient Coinfected With the Different SARS‐CoV‐2 Variants},
journal = {Influenza and Other Respiratory Viruses},
year = {2024},
doi = {10.1111/irv.13340}
}
EUVIMED